FreeStyle Libre 3 vs Dexcom G7: Which CGM for RPM?

Choosing Between Two iCGM Platforms for Remote Monitoring

FreeStyle Libre 3 and Dexcom G7 are the two leading iCGM platforms in the United States. Both are FDA-cleared, factory calibrated, and supported by cloud APIs that enable remote patient monitoring without additional hardware. But the sensors differ in specifications that directly affect RPM program operations — sensor wear duration, reading frequency, warmup time, and integration architecture.

This comparison focuses on the attributes that matter for RPM programs: clinical data density, patient compliance, staff burden, and billing documentation.

Head-to-Head Specifications

Specification	FreeStyle Libre 3	Dexcom G7
Manufacturer	Abbott	Dexcom
FDA Classification	iCGM	iCGM
Sensor Wear	14 days	10 days
Reading Frequency	Every 1 minute	Every 5 minutes
Daily Readings	1,440	288
MARD Accuracy	7.9%	8.2%
Warmup Time	60 minutes	30 minutes
Calibration	Factory (no fingersticks)	Factory (no fingersticks)
Scanning Required	No	No
Connectivity	Bluetooth LE → smartphone app	Bluetooth LE → smartphone app
Cloud Platform	LibreView	Dexcom Clarity
Water Resistance	1m / 30 min	2.4m / 24 hrs
Sensor Size	Smallest iCGM available	Compact (60% smaller than G6)

Sensor Wear: 14 Days vs 10 Days

FreeStyle Libre 3's 14-day sensor wear means 26 sensor changes per year. Dexcom G7's 10-day wear requires approximately 36 sensor changes per year — 10 additional patient touchpoints per year per patient.

For RPM programs managing hundreds of patients, the operational difference compounds. Each sensor change is an opportunity for a gap in data: the patient must apply a new sensor, wait for warmup, and confirm Bluetooth pairing. Programs with elderly populations or memory care residents — where staff often assist with sensor application — save meaningful nursing time with fewer change cycles.

The 14-day wear also reduces inventory complexity and supply chain touchpoints, since fewer sensors are ordered, shipped, and tracked per patient per year.

Reading Frequency: Every Minute vs Every 5 Minutes

FreeStyle Libre 3 generates 1,440 glucose readings per day. Dexcom G7 generates 288. Both far exceed the data density of fingerstick monitoring (typically 1–4 readings per day), but the 5x difference between the two CGMs affects certain clinical analytics.

For standard RPM program operations — threshold alerts, daily trend summaries, and CPT 99454 compliance documentation — both reading frequencies are more than sufficient. A sensor that transmits every 5 minutes still documents device transmission on every calendar day the sensor is active.

Where the difference matters is in granular time-in-range analysis, overnight hypoglycemia detection, and rapid glycemic variability assessments. Minute-by-minute data provides higher resolution for identifying short-duration glucose excursions that 5-minute intervals may smooth over.

For most RPM programs focused on chronic disease management and billing compliance, either frequency is clinically adequate. Programs with endocrinology oversight or insulin titration workflows may prefer the higher resolution.

Cloud Integration Architecture

Both CGMs integrate with CCN Health through cloud-to-cloud APIs — no cellular gateways, hubs, or dedicated hardware required.

FreeStyle Libre 3 → LibreView → CCN Health Abbott's LibreView platform serves as the data aggregation layer. Patients use the FreeStyle Libre app on their smartphone, which syncs to LibreView automatically. CCN Health pulls data from the LibreView API on a scheduled basis.

Dexcom G7 → Dexcom Clarity → CCN Health Dexcom's Clarity platform performs the same role. Patients use the Dexcom G7 app, which syncs to Clarity. CCN Health pulls data from the Clarity API.

Both integration paths deliver the same end result: glucose data appears in the CCN Health platform, triggers clinical alerts, generates EHR documentation, and populates billing records — without any manual data entry.

RPM Billing Compliance

Both sensors satisfy the CPT 99454 requirement for device data transmission (at least 16 days per calendar month with recorded data). Since both CGMs transmit continuously while the sensor is active, the limiting factor is sensor uptime — not reading frequency.

With Dexcom G7's 10-day wear, a patient needs at least two sensor sessions per month with no gaps exceeding 14 days to meet the 16-day threshold. With FreeStyle Libre 3's 14-day wear, a single sensor session covers 14 of the required 16 days, and the second sensor of the month completes the remainder with margin.

In practice, both achieve reliable 99454 compliance when patients maintain consistent sensor wear. The longer wear period of Libre 3 provides a slightly larger buffer against gaps caused by sensor falloff, delayed replacement, or supply delays.

Care Setting Considerations

Senior Living and Memory Care

FreeStyle Libre 3's 14-day wear and no-scan operation are advantages in settings where clinical staff manage sensor application. Fewer sensor changes means less hands-on time per resident. The Libre 3 is also the smallest and thinnest iCGM sensor available, which reduces the likelihood of accidental dislodging — a common issue in memory care where patients may not understand the sensor's purpose.

Physician Practices and Home Health

In settings where patients self-manage their CGM, the choice often depends on which device the patient's endocrinologist has already prescribed. RPM programs that accept both CGMs can enroll patients regardless of their existing device. CCN Health normalizes data from both platforms into a unified clinical view, so the care team's workflow is identical regardless of which sensor the patient wears.

Skilled Nursing Facilities

Skilled nursing facilities benefit from whichever CGM the facility has standardized on. The operational efficiency of a single-device program (one sensor type to stock, one application procedure to train) typically outweighs the specification differences between the two sensors.

Making the Choice

For new RPM programs selecting a primary CGM: FreeStyle Libre 3's longer wear and higher reading frequency make it the default recommendation for programs optimizing for operational efficiency and data density. Dexcom G7's faster warmup and broader third-party ecosystem (more smartwatch integrations, more insulin pump partnerships) make it the better fit for programs with an endocrinology focus or existing Dexcom relationships.

For established programs: support both. Many patients arrive with a CGM already prescribed by their endocrinologist. Requiring a switch creates friction, delays enrollment, and may not be clinically justified. CCN Health's platform normalizes data from both, making dual-device support operationally transparent.

FAQ

Can I use both FreeStyle Libre 3 and Dexcom G7 in the same RPM program?

Yes. CCN Health integrates with both LibreView and Dexcom Clarity APIs. Data from both CGMs flows into the same clinical dashboards, alert systems, and billing documentation. Care teams see a unified view regardless of which sensor type each patient wears.

Which CGM is better for Medicare RPM billing?

Both satisfy CPT 99454 device transmission requirements. The clinical and billing outcome is identical — the difference is operational (sensor wear duration, reading frequency, staff burden for sensor changes).

Does CCN Health support FreeStyle Libre 2 in addition to Libre 3?

Both FreeStyle Libre 2 and Libre 3 sync to LibreView. If a patient is using Libre 2 (with or without the real-time streaming upgrade), their data flows through the same integration path.

Do patients need any special setup for CGM data to reach CCN Health?

Patients need the manufacturer's smartphone app (FreeStyle Libre app or Dexcom G7 app) installed and connected to their sensor via Bluetooth. Data syncs to the cloud automatically from there. No additional apps, gateways, or patient-side configuration is required.